Company Filing History:
1 out of 280 
1 out of 26 
1 out of 1 Years Active: 2013
Title: Frédéric Pinguet: Innovator in Cancer Treatment
Introduction
Frédéric Pinguet is a notable inventor based in Montarnaud, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Pinguet holds a patent for "Imidazol[1,2-α]quinoxalines and derivatives for the treatment of cancers." This patent includes Imidazo[1,2-a]quinoxaline compounds that are designed for therapeutic use in treating various cancers. The compounds are characterized by a general formula that outlines their chemical structure and potential applications in medical therapy.
Career Highlights
Throughout his career, Frédéric Pinguet has worked with esteemed institutions such as Université de Montpellier and the American University of Beirut. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Pinguet has collaborated with notable colleagues, including Carine Deleuze-Masquefa and Georges Moarbess. These partnerships have contributed to the development of his innovative cancer treatment solutions.
Conclusion
Frédéric Pinguet's work in the field of cancer treatment exemplifies the impact of innovative research on healthcare. His patent and collaborations highlight his commitment to advancing medical science and improving patient outcomes.